Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
about
Angioplasty versus bare metal stenting for superficial femoral artery lesionsAtherectomy for peripheral arterial diseaseNew developments in the clinical use of drug-coated balloon catheters in peripheral arterial diseaseSupera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidenceKorean Guidelines for Interventional Recanalization of Lower Extremity ArteriesPatterns of femoropopliteal recurrence after routine and selective stenting endoluminal therapy.Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stentOutcomes following treatment of femoropopliteal in-stent restenosis: a single center experience.Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.Optimal management of infrainguinal arterial occlusive diseaseBare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial.Effects of recombinant human type I pancreatic elastase on human atherosclerotic arteriesDrug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.Commentary: Excimer Laser in Treating Femoropopliteal In-Stent Restenosis: Can Early Success Be Maintained Over Long-term Follow-up?Early results with LifeStent implantation in RESILIENT and non-RESILIENT inclusion criteria patients.Clinical outcomes after endovascular treatment of superficial femoral disease in patients with disabling claudication and critical limb ischemia: midterm analysisOutcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery diseaseOff-resonance magnetic resonance angiography improves visualization of in-stent lumen in peripheral nitinol stents compared to conventional T1-weighted acquisitions: an in vitro comparison study.An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC SteeringProspective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary ResultsFemoropopliteal Artery Stent Thrombosis: Report From the Excellence in Peripheral Artery Disease Registry.A budget impact model for paclitaxel-eluting stent in femoropopliteal disease in FranceComparison between superficial femoral artery stenting and bypass surgery in severe lower-limb ischaemia: a retrospective study.Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized TrialRecombinant Human Elastase Alters the Compliance of Atherosclerotic Tibial Arteries After Ex Vivo Angioplasty.Management of Critical Limb Ischemia.Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.A single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial.Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention.Peripheral artery disease. Part 2: medical and endovascular treatment.Ten years after arterial bypass surgery for claudication: venous bypass is the primary procedure for TASC C and D lesions.Current state of diagnosis and management of critical limb ischemia.Endovascular treatment of critical ischemia in the diabetic foot: new thresholds, new anatomies.Endovascular stents: a review of their use in peripheral arterial disease.Endovascular techniques in limb salvage: stents.Systematic review and meta-analysis of additional technologies to enhance angioplasty for infrainguinal peripheral arterial occlusive disease.Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies.An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors.
P2860
Q24193807-4114CB7F-5E67-4F22-BB52-E55558D3D13AQ24197925-3A0565FB-D7D6-46FB-8CE7-0CD5415222CAQ26740218-943D1ACA-504C-4BD7-BDCA-410089CE4852Q26800276-2832E754-B0F4-4441-9A5F-930C3A6AC8A5Q26801709-30BD9D60-57AA-4A81-A96D-745D6EC5B49DQ33635120-311D818C-2836-4E65-B765-C5FF50836A7EQ33710114-F10C23EA-84E1-4A33-9514-51E04E0DBF10Q33898005-BD2DF46B-D081-4174-95CC-78B70CBBA906Q34197695-8530A4A4-42F7-4AE6-A46F-29C678AD6F11Q34227383-60C011F5-A314-4D19-89B4-498081D4D2C0Q34434785-B87482A8-7910-4504-BA67-EDFE16E7F896Q34484871-DAC2ECC2-ED7C-4C27-ACC3-52E78F642EEAQ34743883-78AAAC50-D1F7-4959-A0CA-D62DC4CFFDEAQ35069850-DDA64F5C-AB91-4923-8BFB-1611B64EB9E4Q35150908-7769EEC3-D964-4E51-A563-78401C06A8D4Q35696046-E4051DFC-097B-4DF5-9F3F-D73CAA14B325Q35765692-981EF0ED-2896-4B5A-90E3-C6E4FCF49A8BQ35766744-24816753-330A-44CE-A1D9-C4C12BB01F67Q35866198-41EE0C7C-6908-479A-9081-25787EB24BF3Q36106277-D4BE8AF8-7BEF-446D-AD6A-FE7DD6603B8AQ36405390-F4A96667-A99B-462D-A088-DCC4B9685BCEQ36523213-225E12CB-B073-48AE-9074-A85917ADC114Q36550874-D6FC1515-4033-4705-ADE9-91531342371EQ36678307-AFD8755C-8F2E-4250-924E-F6B98D6432C0Q36747884-A169C5F4-B78D-4C8E-AC6D-3C2B02F05343Q36774583-EEDC2C53-EE8A-46E0-89A4-C17FD179732AQ36786223-42DD3A47-C780-410D-9F48-E4BD9AFF5395Q36786241-06642C94-B739-4D83-A9FB-E00459235B96Q36920052-47FFC6C3-96AC-4E01-9644-DBDF7719969DQ37257331-48B05326-1724-43B7-8918-C7D95E2B7FC9Q37333232-99080BB6-5093-4ADF-AEF2-09BB301CF3C3Q37889106-70210C60-3C1A-4A87-8BDC-873A334AE5AEQ37919406-565293CF-FB7F-47E8-B53F-53AA73E40FB3Q37981977-21A4BE8F-9FD5-4F7D-93BC-A7DFB7C1B73DQ38058074-7C640036-8A14-4FF2-89D2-0B344C8B8183Q38098451-7092DFC7-2F94-4B4C-B095-513C7685A45EQ38117375-A8B4F0DA-DCBE-4E2E-8BD8-58D9C5913A2EQ38120675-489E8619-4DC0-42DA-B0F6-2DA45FADB077Q38133465-641DAE4F-3151-4E7B-A5A1-269AC1310573Q38179363-7F8B66AB-1698-478D-858B-C646D2D43CB8
P2860
Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Nitinol stent implantation ver ...... he RESILIENT randomized trial.
@en
type
label
Nitinol stent implantation ver ...... he RESILIENT randomized trial.
@en
prefLabel
Nitinol stent implantation ver ...... he RESILIENT randomized trial.
@en
P2093
P1476
Nitinol stent implantation ver ...... he RESILIENT randomized trial.
@en
P2093
Alexandra Lansky
Barry T Katzen
Dierk Scheinert
Ecaterina Cristea
Gary Ansel
Jeffrey Carpenter
Jeffrey Goldstein
Johannes Lammer
John R Laird
Maurice Buchbinder
P304
P356
10.1161/CIRCINTERVENTIONS.109.903468
P577
2010-05-18T00:00:00Z